BKD vs VERA
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
BKD · Brookdale Senior Living$9.01 ▼ 16.65%
VERA · Vera Therapeutics$29.79 ▼ 1.18%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- BKD -9.1%
- VERA +7.3%
Head to head
| Metric | BKD | VERA |
|---|---|---|
| Price | $9.01 | $29.79 |
| Change today | ▼ 16.65% | ▼ 1.18% |
| Market cap | $2.15B | $2.15B |
| Return, 3 months | -34.2% | -5.7% |
| Return, year to date | -16.5% | -41.2% |
| Return, 1 year | -4.5% | +23.1% |
| P/E (TTM) | – | – |
| P/B | -74.5 | 6.5 |
| P/E percentile vs own 5y | 6th | 72nd |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | -11.6% | – |
| Net profit growth (YoY) | +154.0% | -43.0% |
| Gross margin | 26.9% | – |
| Operating margin | 4.5% | – |
| Net margin | -4.5% | – |
| Return on equity | -362.1% | -91.8% |
| Analyst target vs. price | +112.3% | +152.9% |
| Analyst buy share | 100% | 91% |
| RSI (14) | 34 | 48 |
| 30-day volatility | 67.9% | 56.6% |
| Max drawdown, 1 year | -46.3% | -52.0% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- VERA is the largest of the group by market value.
- VERA has returned the most over the past year.
- VERA has been the calmest stock over the last 30 days.